Intellia Therapeutics Other Long Term Liabilities (Quarterly) Trends

Intellia Therapeutics, Inc. (NTLA)

13.44 +0.28 (+2.13%) USD | NASDAQ | Feb 24, 11:45

View Other Long Term Liabilities (Quarterly) for NTLA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Beam Therapeutics, Inc.	Upgrade
Personalis, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Pacific Biosciences of California, Inc.	--
Twist Bioscience Corp.	Upgrade